Australia's most trusted
source of pharma news
Thursday, 14 May 2026
Posted 14 May 2026 AM
After leaving the pharma industry in 2024, Belinda Wood is back joining the Board of Inherited Cancers Australia (ICA).
Woods built an extensive career in health and pharmaceutical policy, serving as CEO of GBMA, Deputy Chief Executive of the Pharmaceutical Society of Australia, and a Medicines Australia Strategic Council Member. She also worked at Novartis for nine years in sales roles.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.